Advances in the diagnosis and management of post-percutaneous coronary intervention coronary microvascular dysfunction: Insights into pathophysiology and metabolic risk interactions

doi:10.4330/wjc.v17.i2.103950

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (0)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series.

Item

Count

PDF

HTML

Figures (1-2)

Sum=0

Feb 26, 2025 (publication date) through Feb 25, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Cardiol. Feb 26, 2025; 17(2): 103950
Published online Feb 26, 2025. doi: 10.4330/wjc.v17.i2.103950

Open in New Tab Full Size Figure Download Figure

Figure 1 The main pathophysiological mechanisms of coronary microvascular dysfunction. NO: Nitric oxide.

Open in New Tab Full Size Figure Download Figure

Figure 2 Coronary microvascular dysfunction management flowchart. CCB: Calcium channel blocker; EECP: Enhanced external counterpulsation; IABP: Intra-aortic balloon pump; SGLT2: Sodium-dependent glucose transporters 2; VA-ECMO: Veno-arterial extracorporeal membrane oxygenation.

Citation: Tang N, Li KM, Li HR, Zhang QD, Hao J, Qi CM. Advances in the diagnosis and management of post-percutaneous coronary intervention coronary microvascular dysfunction: Insights into pathophysiology and metabolic risk interactions. World J Cardiol 2025; 17(2): 103950
URL: https://www.wjgnet.com/1949-8462/full/v17/i2/103950.htm
DOI: https://dx.doi.org/10.4330/wjc.v17.i2.103950